The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats
- 1 January 1994
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 134 (1) , 507-510
- https://doi.org/10.1210/en.134.1.507
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: